BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scanlon SA, Murray JA. Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances. Clin Exp Gastroenterol. 2011;4:297-311. [PMID: 22235174 DOI: 10.2147/ceg.s8315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Ido H, Matsubara H, Kuroda M, Takahashi A, Kojima Y, Koikeda S, Sasaki M. Combination of Gluten-Digesting Enzymes Improved Symptoms of Non-Celiac Gluten Sensitivity: A Randomized Single-blind, Placebo-controlled Crossover Study. Clin Transl Gastroenterol 2018;9:181. [PMID: 30228265 DOI: 10.1038/s41424-018-0052-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Alsaadi D, Shah NJ, Charabaty A, Atkins MB. A case of checkpoint inhibitor-induced celiac disease. J Immunother Cancer 2019;7:203. [PMID: 31383006 DOI: 10.1186/s40425-019-0694-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 DeGeorge KC, Frye JW, Stein KM, Rollins LK, McCarter DF. Celiac Disease and Gluten Sensitivity. Prim Care 2017;44:693-707. [PMID: 29132529 DOI: 10.1016/j.pop.2017.07.011] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Loberman-Nachum N, Sosnovski K, Di Segni A, Efroni G, Braun T, BenShoshan M, Anafi L, Avivi C, Barshack I, Shouval DS, Denson LA, Amir A, Unger R, Weiss B, Haberman Y. Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis. Sci Rep 2019;9:16163. [PMID: 31700112 DOI: 10.1038/s41598-019-52733-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Bul V, Sleesman B, Boulay B. Celiac Disease Presenting as Profound Diarrhea and Weight Loss - A Celiac Crisis. Am J Case Rep. 2016;17:559-561. [PMID: 27492679 DOI: 10.12659/ajcr.898004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Parzanese I, Qehajaj D, Patrinicola F, Aralica M, Chiriva-Internati M, Stifter S, Elli L, Grizzi F. Celiac disease: From pathophysiology to treatment. World J Gastrointest Pathophysiol 2017; 8(2): 27-38 [PMID: 28573065 DOI: 10.4291/wjgp.v8.i2.27] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 45] [Article Influence: 15.2] [Reference Citation Analysis]
7 Leonard MM, Bai Y, Serena G, Nickerson KP, Camhi S, Sturgeon C, Yan S, Fiorentino MR, Katz A, Nath B, Richter J, Sleeman M, Gurer C, Fasano A. RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis. PLoS One 2019;14:e0215132. [PMID: 30998704 DOI: 10.1371/journal.pone.0215132] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sandhu DK, Surawicz C. Update on chronic diarrhea: a run-through for the clinician. Curr Gastroenterol Rep 2012;14:421-7. [PMID: 22903799 DOI: 10.1007/s11894-012-0283-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Almazar AE, Talley NJ, Larson JJ, Atkinson EJ, Murray JA, Saito YA. Celiac disease is uncommon in irritable bowel syndrome in the USA. Eur J Gastroenterol Hepatol 2018;30:149-54. [PMID: 29240001 DOI: 10.1097/MEG.0000000000001022] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Domżał-Magrowska D, Kowalski MK, Szcześniak P, Bulska M, Orszulak-Michalak D, Małecka-Panas E. The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes. Prz Gastroenterol 2016;11:276-81. [PMID: 28053683 DOI: 10.5114/pg.2016.57941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Haberman Y, Iqbal NT, Ghandikota S, Mallawaarachchi I, Tzipi Braun, Dexheimer PJ, Rahman N, Hadar R, Sadiq K, Ahmad Z, Idress R, Iqbal J, Ahmed S, Hotwani A, Umrani F, Ehsan L, Medlock G, Syed S, Moskaluk C, Ma JZ, Jegga AG, Moore SR, Ali SA, Denson LA. Mucosal Genomics Implicate Lymphocyte Activation and Lipid Metabolism in Refractory Environmental Enteric Dysfunction. Gastroenterology 2021;160:2055-2071.e0. [PMID: 33524399 DOI: 10.1053/j.gastro.2021.01.221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
12 Yokoyama S, Perera PY, Waldmann TA, Hiroi T, Perera LP. Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease.J Clin Immunol. 2013;33:586-594. [PMID: 23269601 DOI: 10.1007/s10875-012-9849-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
13 Pantazes RJ, Reifert J, Bozekowski J, Ibsen KN, Murray JA, Daugherty PS. Identification of disease-specific motifs in the antibody specificity repertoire via next-generation sequencing. Sci Rep 2016;6:30312. [PMID: 27481573 DOI: 10.1038/srep30312] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
14 Sen P, Carlsson C, Virtanen SM, Simell S, Hyöty H, Ilonen J, Toppari J, Veijola R, Hyötyläinen T, Knip M, Orešič M. Persistent Alterations in Plasma Lipid Profiles Before Introduction of Gluten in the Diet Associated With Progression to Celiac Disease. Clin Transl Gastroenterol 2019;10:1-10. [PMID: 31082858 DOI: 10.14309/ctg.0000000000000044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
15 Cruz IT, Fraiz FC, Celli A, Amenabar JM, Assunção LR. Dental and oral manifestations of celiac disease. Med Oral Patol Oral Cir Bucal 2018;23:e639-45. [PMID: 30341262 DOI: 10.4317/medoral.22506] [Cited by in F6Publishing: 3] [Reference Citation Analysis]